NOVA LEAP HEALTH CORP (NLH.CA) Stock Fundamental Analysis
TSX-V:NLH - TSX Venture Exchange - CA66980G1090 - Common Stock - Currency: CAD
We assign a fundamental rating of 4 out of 10 to NLH. NLH was compared to 15 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of NLH get a neutral evaluation. Nothing too spectacular is happening here. NLH does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
NLH had positive earnings in the past year.
NLH had a positive operating cash flow in the past year.
In multiple years NLH reported negative net income over the last 5 years.
NLH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 3.57%, NLH is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
The Return On Equity of NLH (4.54%) is better than 66.67% of its industry peers.
NLH's Return On Invested Capital of 3.00% is fine compared to the rest of the industry. NLH outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.57% | ||
| ROE | 4.54% | ||
| ROIC | 3% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 3.13%, NLH is in line with its industry, outperforming 60.00% of the companies in the same industry.
NLH's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 2.85%, NLH is in line with its industry, outperforming 60.00% of the companies in the same industry.
NLH has a Gross Margin (38.64%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of NLH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.85% | ||
| PM (TTM) | 3.13% | ||
| GM | 38.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
2. Health
2.1 Basic Checks
NLH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
NLH has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NLH has more shares outstanding
The debt/assets ratio for NLH is higher compared to a year ago.
2.2 Solvency
NLH has an Altman-Z score of 3.17. This indicates that NLH is financially healthy and has little risk of bankruptcy at the moment.
NLH has a Altman-Z score of 3.17. This is amongst the best in the industry. NLH outperforms 86.67% of its industry peers.
NLH has a debt to FCF ratio of 2.82. This is a good value and a sign of high solvency as NLH would need 2.82 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.82, NLH belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
A Debt/Equity ratio of 0.05 indicates that NLH is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.05, NLH belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 2.82 | ||
| Altman-Z | 3.17 |
ROIC/WACC0.4
WACC7.5%
2.3 Liquidity
A Current Ratio of 0.82 indicates that NLH may have some problems paying its short term obligations.
The Current ratio of NLH (0.82) is comparable to the rest of the industry.
A Quick Ratio of 0.82 indicates that NLH may have some problems paying its short term obligations.
NLH has a Quick ratio of 0.82. This is comparable to the rest of the industry: NLH outperforms 46.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
NLH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 382.35%, which is quite impressive.
NLH shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.19% yearly.
NLH shows a small growth in Revenue. In the last year, the Revenue has grown by 0.81%.
The Revenue has been growing by 8.16% on average over the past years. This is quite good.
EPS 1Y (TTM)382.35%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%-116.67%
Revenue 1Y (TTM)0.81%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%10.33%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 26.50, the valuation of NLH can be described as expensive.
73.33% of the companies in the same industry are more expensive than NLH, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of NLH to the average of the S&P500 Index (26.65), we can say NLH is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.5 | ||
| Fwd PE | N/A |
4.2 Price Multiples
66.67% of the companies in the same industry are more expensive than NLH, based on the Enterprise Value to EBITDA ratio.
NLH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NLH is cheaper than 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.15 | ||
| EV/EBITDA | 13.59 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NLH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:NLH (6/20/2025, 7:00:00 PM)
0.265
+0.02 (+6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners18.98%
Ins Owner ChangeN/A
Market Cap23.14M
Analysts84.44
Price Target0.61 (130.19%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.5 | ||
| Fwd PE | N/A | ||
| P/S | 0.64 | ||
| P/FCF | 14.15 | ||
| P/OCF | 13.86 | ||
| P/B | 0.92 | ||
| P/tB | 24.4 | ||
| EV/EBITDA | 13.59 |
EPS(TTM)0.01
EY3.77%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY7.06%
OCF(TTM)0.02
OCFY7.21%
SpS0.42
BVpS0.29
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.57% | ||
| ROE | 4.54% | ||
| ROCE | 3.95% | ||
| ROIC | 3% | ||
| ROICexc | 3.23% | ||
| ROICexgc | 269.04% | ||
| OM | 2.85% | ||
| PM (TTM) | 3.13% | ||
| GM | 38.64% | ||
| FCFM | 4.49% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
F-Score6
Asset Turnover1.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 2.82 | ||
| Debt/EBITDA | 0.62 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 6.07 | ||
| Cash Conversion | 87.57% | ||
| Profit Quality | 143.33% | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 3.17 |
F-Score6
WACC7.5%
ROIC/WACC0.4
Cap/Depr(3y)4.23%
Cap/Depr(5y)2.79%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)382.35%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%-116.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.81%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%10.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-9.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.06%
FCF growth 3Y-14.49%
FCF growth 5Y17.9%
OCF growth 1Y27.88%
OCF growth 3Y-13.97%
OCF growth 5Y17.73%